6533b862fe1ef96bd12c77ac
RESEARCH PRODUCT
Letter: proton pump inhibitor use and bone fracture risk-a mechanistic point of view. Authors' reply
Jörn M. SchattenbergChristian Labenzsubject
Liver CirrhosisMaleHepatologymedicine.drug_classbusiness.industryGastroenterologyProton-pump inhibitorProton Pump InhibitorsBone fracturemedicine.diseaseBioinformaticsFractures BonemedicineHumansPharmacology (medical)Point (geometry)businessyear | journal | country | edition | language |
---|---|---|---|---|
2021-02-10 | Alimentary Pharmacology & Therapeutics |